Association of Preoperative Pain With Moderate to Severe Acute Pain After Laparoscopic Cholecystectomy: A Prospective Observational Study

Sponsor
B.P. Koirala Institute of Health Sciences (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05543668
Collaborator
(none)
195
1
10
19.5

Study Details

Study Description

Brief Summary

Despite advancement in perioperative pain management, more than half of the patients still report moderate-severe pain after surgery. Among several risk factors, pre-existing pain has consistently been shown to predict postoperative severe pain.If one can predict the patients who will experience more post-operative pain, then a more aggressive pain management strategy can be adopted perioperatively. This would improve patient satisfaction and prevent poor outcomes such as chronic pain after surgery. Therefore, our primary aim is to find out whether presence of pre-existing preoperative pain would predict moderate-severe acute pain after laparoscopic cholecystectomy. Moreover, we plan to use Patient Reported Outcomes Measurement Information System (PROMIS) scale to assess preoperative pain intensity and pain-related behaviors.

Primary &Secondary Objectives:

Primary objectives To investigate the association between preexisting preoperative pain (more than 3 months duration) and postoperative moderate-severe acute pain after laparoscopic cholecystectomy.

Secondary objectives

  1. To investigate the association between preoperative PROMIS domain (PROMIS pain intensity score, PROMIS pain interference score, PROMIS pain behavioural score) and postoperative moderate-severe acute pain after laparoscopic cholecystectomy.

  2. To investigate the association between preexisting preoperative pain and postoperative total opioid consumption.

  3. To identify the risk factors associated with postoperative moderate-severe acute pain after laparoscopic cholecystectomy.

  4. To compare postoperative pain interference scores between patients who reports moderate-severe pain and those who do not.

  5. To identify the risk factors associated with shoulder tip pain after laparoscopic cholecystectomy.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Patients who are 18 years of age and scheduled for elective laparoscopic cholecystectomy under general anesthesia will be enrolled in this prospective observational study. Perioperative anesthesia management will be standardized for all patients.

    Variables such as age, sex, preexisting preoperative pain (chronic or subacute), preoperative PROMIS pain intensity, PROMIS behavior, PROMIS interference, PROMIS depression, PROMIS sleep disturbance, APAIS score, catastrophizing pain score, neuroticism (EPQRS score), preoperative pain sensitivity, an expectation of the postoperative pain and intraoperative surgical variables will be recorded.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    195 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Association of Preoperative Pain With Moderate to Severe Acute Pain After Laparoscopic Cholecystectomy: A Prospective Observational Study
    Anticipated Study Start Date :
    Oct 1, 2022
    Anticipated Primary Completion Date :
    Jul 30, 2023
    Anticipated Study Completion Date :
    Aug 1, 2023

    Arms and Interventions

    Arm Intervention/Treatment
    preexisting preoperative chronic pain

    Patients with preexisting preoperative chronic pain (more than 3 months duration).

    preexisting preoperative sub-acute pain

    Patients with preexisting preoperative sub-acute pain (less than 3 months duration).

    No pain preoperatively

    Patients without preexisting preoperative pain.

    Outcome Measures

    Primary Outcome Measures

    1. Occurrence of acute moderate to severe postoperative pain. [up to 24 hours postoperatively.]

      numerical pain rating scale (NPRS) more than or equal to 4.

    Secondary Outcome Measures

    1. Total opioids consumed in morphine equivalent (mg). [up to 24 hours postoperatively.]

      morphine equivalents in mg

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    All patients undergoing laparoscopic cholecystectomy

    • Age group (more than or equal to 18 years)

    • All ASA physical status patients.

    • Ability to use NPRS scale, PROMIS scale, pain catastrophizing scale, APAIS, neuroticism EPQRS scale, and to understand and follow simple instructions.

    Exclusion Criteria:

    All patient with

    • Not willing to participate in the study

    • Severe Neurological and Psychiatric disorder(eg. dementia)

    • Pregnant women

    • Acute cholecystitis managed conservatively.

    • Cognitive impairments (lack of capacity to provide informed consent)

    • Choledocholithiasis

    • Features of obstructive jaundice.

    • Unable to communicate (eg. Language barrier or deaf)

    • Open cholecystectomy or laparoscopic cholecystectomy converted to open cholecystectomy

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 B.P. Koirala Institute of Health Sciences Dharān Bāzār Province O1 Nepal 56700

    Sponsors and Collaborators

    • B.P. Koirala Institute of Health Sciences

    Investigators

    • Study Chair: Asish Subedi, MD, BP Koirala Institute of Health Sciences

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    BISHAL NEPALI, Junior resident, B.P. Koirala Institute of Health Sciences
    ClinicalTrials.gov Identifier:
    NCT05543668
    Other Study ID Numbers:
    • IRC/2283/022
    First Posted:
    Sep 16, 2022
    Last Update Posted:
    Sep 16, 2022
    Last Verified:
    Sep 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by BISHAL NEPALI, Junior resident, B.P. Koirala Institute of Health Sciences
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 16, 2022